| Deborah H Nichols, MSCCC-SLP | |
|
3165 Raines Ct, Pensacola, FL 32514-6268 | |
| (850) 478-6100 | |
| Not Available |
| Full Name | Deborah H Nichols |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3165 Raines Ct, Pensacola, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174646236 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SA679 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah H Nichols, MSCCC-SLP 3165 Raines Ct, Pensacola, FL 32514-6268 Ph: (850) 478-6100 | Deborah H Nichols, MSCCC-SLP 3165 Raines Ct, Pensacola, FL 32514-6268 Ph: (850) 478-6100 |
News Archive
Scientists headed by ICREA researcher Angel R. Nebreda at the Institute for Research in Biomedicine report a new mechanism that contributes to the development of inflammation-associated colon cancer and points to new therapeutic targets
The culture of silence around vaginal bleeding at all stages of life endangers women's health and is compounded by limited access to clean water, sanitation, and factual information in low and middle-income countries, according to a study conducted at Columbia University's Mailman School of Public Health. The findings are published in the online journal BMJ Global Health.
The InDanio screening system can be used, for example, to functionally characterize 'orphan' receptors - those for which their natural ligands or specific function are unknown - and thus qualify them as potential targets for drug discovery. The system can also be used to screen compound libraries in order to identify and refine potential new drugs that target NR proteins.
Future Science Group today announced the publication of a new article in Future Science OA looking to identify and define key terms associated with bioinks and bioprinting.
Eisai Inc. and Helsinn Group today announced the Food and Drug Administration (FDA) approval of ALOXI (palonosetron HCl) injection for the prevention of acute nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including highly emetogenic cancer chemotherapy, in children aged 1 month to less than 17 years.
› Verified 5 days ago
Mrs. Nicole Christine Sherick, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10100 Hillview Dr, Pensacola, FL 32514 Phone: 850-478-5153 | |
Kindle Page, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 W Moreno St, Physical Therapy, Pensacola, FL 32501 Phone: 850-434-4971 | |
Daryla Jeanine Shakley, M.A., CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 413 Childers St, Pensacola, FL 32534 Phone: 623-256-7730 | |
Mr. Juan Suarez, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5120 Bayou Blvd, Suite 6, Pensacola, FL 32503 Phone: 413-246-1445 | |
Gulf Coast Speech Language Services, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5972 Dahoon Dr, Pensacola, FL 32526 Phone: 850-380-4063 | |
Mr. Michael John Zavison Ii, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6982 Pine Forest Rd, Pensacola, FL 32526 Phone: 850-750-5203 | |
Mrs. Barbara J Kahalley, ST Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9400 University Pkwy, Baptist Medical Park, Pensacola, FL 32514 Phone: 850-208-6120 |